drugset / Trial / NCT02115581

Coenzyme Q10 Supplementation in Children With Idiopathic Dilated Cardiomyopathy

NCT02115581

Phase 4 Completed 38 enrolled University of Tehran
RandomizedParallel-groupDouble-blindTreatment

Summary

This study aims to determine the effect of Coenzyme Q10 supplementation on conventional therapy of children with heart failure due to idiopathic dilated cardiomyopathy.

Timeline

Start
2006-09
Primary completion
2008-03
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Coenzyme Q10 Other / unclassified 10 mg/kg